209 related articles for article (PubMed ID: 38254885)
1. The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Narvaez D; Nadal J; Nervo A; Costanzo MV; Paletta C; Petracci FE; Rivero S; Ostinelli A; Freile B; Enrico D; Pombo MT; Amat M; Aguirre ED; Chacon M; Waisberg F
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254885
[TBL] [Abstract][Full Text] [Related]
2. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
3. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
Song IH; Heo SH; Bang WS; Park HS; Park IA; Kim YA; Park SY; Roh J; Gong G; Lee HJ
Cancer Res Treat; 2017 Apr; 49(2):399-407. PubMed ID: 27488875
[TBL] [Abstract][Full Text] [Related]
5. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
[TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters.
Zeng L; Koh VCY; Chen XY; Tan PH
Histopathology; 2023 Apr; 82(5):779-788. PubMed ID: 36635954
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the tertiary lymphoid structures with the tumor-infiltrating lymphocytes and its prognostic value in gastric cancer.
Zhang N; Zhang G; Wang D; Liu H; Zhang Y; Ayarick VA; Han X; Lv Y; Wang Y
Arch Med Sci; 2024; 20(1):255-266. PubMed ID: 38414448
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures in the era of cancer immunotherapy.
Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
[TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G
J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.
Solinas C; Garaud S; De Silva P; Boisson A; Van den Eynden G; de Wind A; Risso P; Rodrigues Vitória J; Richard F; Migliori E; Noël G; Duvillier H; Craciun L; Veys I; Awada A; Detours V; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
Front Immunol; 2017; 8():1412. PubMed ID: 29163490
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis.
Zhang NN; Qu FJ; Liu H; Li ZJ; Zhang YC; Han X; Zhu ZY; Lv Y
Cancer Cell Int; 2021 Oct; 21(1):536. PubMed ID: 34654433
[TBL] [Abstract][Full Text] [Related]
15. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures.
Magara T; Nakamura M; Nojiri Y; Yoshimitsu M; Kano S; Kato H; Morita A
Front Oncol; 2023; 13():1106434. PubMed ID: 37081973
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
[TBL] [Abstract][Full Text] [Related]
17. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract][Full Text] [Related]
18. CD8
Li Q; Zhang D; He W; Chen T; Yan Z; Gao X; Chen L; Zheng X; Xu B; Lu B; Jiang J
Oncol Lett; 2020 Sep; 20(3):2655-2664. PubMed ID: 32782582
[TBL] [Abstract][Full Text] [Related]
19. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors.
Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316
[TBL] [Abstract][Full Text] [Related]
20. The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers.
Ware MB; Wolfarth AA; Goon JB; Ezeanya UI; Dhar S; Ferrando-Martinez S; Lee BH
J Immunother Precis Oncol; 2022 Nov; 5(4):105-117. PubMed ID: 36483588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
